| Literature DB >> 31644912 |
Ajai Tripathi1, Christina Volsko1, Jessie P Garcia2, Eneritz Agirre3, Kevin C Allan4, Paul J Tesar4, Bruce D Trapp1, Goncalo Castelo-Branco3, Fraser J Sim2, Ranjan Dutta5.
Abstract
Remyelination requires the generation of new oligodendrocytes (OLs), which are derived from oligodendrocyte progenitor cells (OPCs). Maturation of OPCs into OLs is a multi-step process. Here, we describe a microRNA expressed by OLs, miR-27a, as a regulator of OL development and survival. Increased levels of miR-27a were found in OPCs associated with multiple sclerosis (MS) lesions and in animal models of demyelination. Increased levels of miR-27a led to inhibition of OPC proliferation by cell-cycle arrest, as well as impaired differentiation of human OPCs (hOPCs) and myelination by dysregulating the Wnt-β-catenin signaling pathway. In vivo administration of miR-27a led to suppression of myelinogenic signals, leading to loss of endogenous myelination and remyelination. Our findings provide evidence supporting a critical role for a steady-state level of OL-specific miR-27a in supporting multiple steps in the complex process of OPC maturation and remyelination.Entities:
Keywords: miRNA; multiple sclerosis; oligodendrocyte progenitor cells; remyelination
Year: 2019 PMID: 31644912 PMCID: PMC6874400 DOI: 10.1016/j.celrep.2019.09.020
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423